|
|
|
|
| LEADER |
00832nam a2200253 a 4500 |
| 001 |
854096 |
| 005 |
20171111231300.0 |
| 008 |
030923s2004n gr gr 000a0 eng d |
| 020 |
|
|
|a 0471601500
|z (cloth)
|
| 082 |
0 |
|
|a 615.19
|
| 100 |
1 |
|
|4 aut
|a Ng, Rick
|
| 245 |
1 |
0 |
|a Drugs :from discovery to approval /
|c Rick Ng.
|
| 260 |
|
|
|a Hoboken, N.J. :
|b Wiley-Liss ,
|c c2004 .
|
| 300 |
|
|
|a xii, 355 p. :
|b ill.
|a 24 cm.
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 650 |
1 |
0 |
|a Clinical Trials
|
| 650 |
1 |
0 |
|a Drug approval
|x Law and legislation
|
| 650 |
1 |
0 |
|a Drug approval
|x Methodology
|
| 650 |
1 |
0 |
|a Drug development
|
| 650 |
1 |
0 |
|a Drugs
|x Design
|
| 650 |
1 |
0 |
|a Pharmaceutical chemistry
|
| 650 |
1 |
0 |
|a Pharmaceutical industry
|
| 650 |
1 |
0 |
|a Pharmaceutical technology
|
| 952 |
|
|
|a GR-AtTEI
|b 59cc7b176c5ad13446fc851d
|c 998a
|d 945l
|e NG
|t 2
|x m
|z Books
|
